Susquehanna Fundamental Investments, LLC Pharma Cyte Biotech, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.24 - $2.85 $77,963 - $99,194	-34,805 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.91 - $2.77 $19,365 - $28,085	-10,139 Reduced 22.56%	34,805 $80,000
Q4 2021 Feb 14, 2022	SELL	$2.4 - $3.19 $11,414 - $15,171	-4,756 Reduced 9.57%	44,944 $112,000
Q3 2021 Nov 15, 2021	BUY	$2.28 - $16.9 $113,315 - $839,929	49,700 New	49,700 $158,000

1.07M

5.4K

400

Ticker PMCB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,750,100
Market Cap $41.5M
Description
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.